Stunting and severe stunting among children under-5 years in Nigeria: A multilevel analysis

Blessing Jaka Akombi1, Kingsley Emwinyore Agho2, John Joseph Hall3

  • 1School of Science and Health, Western Sydney University, Locked Bag 1797, Penrith, NSW, 2571, Australia. B.Akombi@westernsydney.edu.au.

BMC Pediatrics
|January 15, 2017
PubMed

Insights

Childhood stunting in Nigeria is linked to male sex, lower household wealth, and poor sanitation. Interventions should address poverty, maternal nutrition, and child feeding for better development.

Area of Science:

  • Pediatrics
  • Public Health
  • Child Development

Background:

  • Childhood stunting is a critical risk factor for impaired physical and mental development in children under five.
  • Stunting primarily occurs within the first 1000 days of life (0-23 months) but can persist until age five.

Purpose of the Study:

  • To examine the factors associated with stunting and severe stunting in Nigerian children under five years of age.

Main Methods:

  • Utilized data from 24,529 children (0-59 months) from the 2013 Nigeria Demographic and Health Survey (NDHS).
  • Defined stunting (Height-for-age z-scores < -2SD) and severe stunting (HFAz < -3SD) using WHO growth references.
  • Employed multilevel logistic regression analyses, accounting for cluster and survey weights, to identify risk factors.

Main Results:

  • Prevalence of stunting was 29% (0-23 months) and 36.7% (0-59 months); severe stunting was 16.4% (0-23 months) and 21% (0-59 months).
  • Significant risk factors included male sex, smaller maternal perceived birth size, poorer household wealth, shorter breastfeeding duration, specific geopolitical zones (North East, North West, North Central), and recent diarrhea episodes.

Conclusions:

  • Policy interventions in Nigeria should prioritize poverty alleviation to combat stunting.
  • Improving women's nutrition, child feeding practices, and household sanitation are crucial for reducing stunting and achieving sustainable development goals.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.6K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K